Update on MED2002

Futura Medical PLC
09 May 2006


For immediate release                                                 9 May 2006


                                  Futura Medical plc
                                  Update on MED2002


Futura Medical plc (AIM: FUM), the pharmaceutical drug and medical device group
that develops innovative products for sexual health, announces that it has been
advised by the major global pharmaceutical group (MGPG) that the formal approval
process is in its final stage.

James Barder, Futura's Chief Executive, said: 'We are informed by MGPG that
MED2002 remains a high priority for them.'



For further information:
Futura Medical plc
James Barder, Chief Executive                          Tel: [phone]
mail to: [e-mail]              www.futuramedical.co.uk


Media enquiries:
Buchanan Communications
Mark Court                                             Tel: [phone]


Futura Medical plc

Futura Medical is an AIM-listed pharmaceutical drug and medical device group
developing innovative products for sexual health.  The Company is developing a
portfolio of products with the intention of licensing their manufacture and
distribution to major pharmaceutical and healthcare groups.   Exclusive
worldwide distribution agreements have already been signed in respect of
Futura's two condom safety products, CSD500 and FLD500, with SSL International
plc, the makers of DurexTM condoms.

Futura's primary focus is on Over the Counter (OTC) products with particular
appeal to men and women who are reluctant to discuss potentially embarrassing
sexual matters with their doctors.



For further information please visit:  www.futuramedical.co.uk




                      This information is provided by RNS
            The company news service from the London Stock Exchange